Prestige Consumer Healthcare Inc. has grown revenue −0.75% a year over three years and 2.4% a year over five. Revenue growth, 3-year annual rate: −0.75% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: +2.4%, growth has slowed since the five-year average. Years of annual history on file: 17, FY2010 to FY2026, as filed.

PBHPrestige Consumer Healthcare Inc.

Healthcare

$48.25-24% 1Y

$48.25

$44.7652 weeks$70.21

Is it growing?

Watch

Growth is fading: earnings down −16% year on year and operating margin narrowing (−3.8 points).

2 to watch, 1 neutral

Revenue trend−1% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +2% a year.

Earnings trend−16% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction−3.8 points operating

Trailing-twelve-month operating margin, 26.2% now against 30.0% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbehind 81% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is PBH growing?

Prestige Consumer Healthcare Inc. has grown revenue −0.75% a year over three years and 2.4% a year over five.

−0.75%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +2.4%
Revenue growth, 5-year rate · −0.75% over three · growth has slowed since the five-year average
Years of annual history on file: 17
Years of annual history on file · FY2010 to FY2026, as filed

Details›